First newly developed ELISA of risk class B declared IVDR-compliant
Anti-TBE Virus ELISA 2.0 (IgG) After EUROIMMUN received the required certificate for its quality management system in accordance with the new European Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in May of this year, the first newly developed IVD product of risk class B has now also been declared IVDR-compliant and launched […]